MY117168A - Composition and method for treating nonalcoholic steatohepatitis - Google Patents

Composition and method for treating nonalcoholic steatohepatitis

Info

Publication number
MY117168A
MY117168A MYPI9805505A MY117168A MY 117168 A MY117168 A MY 117168A MY PI9805505 A MYPI9805505 A MY PI9805505A MY 117168 A MY117168 A MY 117168A
Authority
MY
Malaysia
Prior art keywords
nonalcoholic steatohepatitis
liver
steatohepatitis
damage
formulations include
Prior art date
Application number
Inventor
David Fan
Houn Simon Hsia
Original Assignee
Viva America Marketing Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viva America Marketing Inc filed Critical Viva America Marketing Inc
Publication of MY117168A publication Critical patent/MY117168A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NONALCOHOLIC STEATOHEPATITIS (NASH) IS A DISEASE OF THE LIVER CHARACTERIZED BY INFLAMMATION AND DAMAGE TO THE LIVER CELLS. TYPICALLY, STEATOHEPATITIS INVOLVES INFLAMMATION OF THE LIVER RELATED TO FAT ACCUMULATION, AND MIMICS ALCOHOLIC HEPATITIS BUT IS OBSERVED IN PATIENTS WHO SELDOM OR NEVER CONSUME ALCOHOL. NONALCOHOLIC STEATOHEPATITIS CAN LEAD TO SERIOUS LIVER DAMAGE, AND ULTIMATELY CIRRHOSIS. THE PRESENT INVENTION PROVIDES METHODS AND COMPOSITIONS USEFUL FOR THE TREATMENT OR ALLEVIATION OF NONALCOHOLIC STEATOHEPATITIS AND THE PHARMACEUTICAL FORMULATIONS FOR THEIR ADMINISTRATION TO A HUMAN. SPECIFICALLY, COMPOSITIONS COMPRISED OF LECITHIN, ANTIOXIDANTS AND VITAMIN B COMPLEX ARE ADMINISTERED PARENTERALLY, MOST PREFERABLY BY ORAL ADMINISTRATION. SPECIFIC THERAPEUTIC FORMULATIONS INCLUDE ADMIXTURES OF THESE COMPOUNDSAND SPECIFIC DOSAGE FORMULATIONS INCLUDE DAILY ORAL ADMINISTRATIONS OF THESE COMPOUNDS IN TABLET OR POWDER FORMS.
MYPI9805505 1997-12-05 1998-12-04 Composition and method for treating nonalcoholic steatohepatitis MY117168A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6732397P 1997-12-05 1997-12-05

Publications (1)

Publication Number Publication Date
MY117168A true MY117168A (en) 2004-05-31

Family

ID=22075227

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9805505 MY117168A (en) 1997-12-05 1998-12-04 Composition and method for treating nonalcoholic steatohepatitis

Country Status (4)

Country Link
AU (1) AU1710299A (en)
MY (1) MY117168A (en)
TW (1) TW548105B (en)
WO (1) WO1999029330A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010763A1 (en) 2001-12-21 2003-06-21 Simone Claudio De NEW LACTIC BACTERIA STOCK AND EDIBLE COMPOSITIONS, DRUGS AND VETERINARY PRODUCTS THAT CONTAIN IT.
EP2584361A4 (en) * 2010-06-17 2014-05-07 Univ Chiba Nat Univ Corp Marker for detection and/or discrimination of non-alcoholic steatohepatitis, method for detection and/or discrimination of non-alcoholic steatohepatitis, and kit for use in the method
US9585857B2 (en) 2013-01-18 2017-03-07 Cornell University Methods of treating diseases associated with high-fat diet and vitamin A deficiency using retinoic acid receptor agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595982A (en) * 1994-03-31 1997-01-21 Harlmen Inc. Equine nutritional supplement

Also Published As

Publication number Publication date
TW548105B (en) 2003-08-21
WO1999029330A1 (en) 1999-06-17
AU1710299A (en) 1999-06-28
WO1999029330A8 (en) 1999-09-10

Similar Documents

Publication Publication Date Title
Takasuna et al. Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats
ATE522211T1 (en) STABILIZED FIBRATE MICROPARTICLES
IL112518A0 (en) Thyroid hormone fast dispersing pharmaceutical composition
HK1061357A1 (en) Fibrate-statin combinations with reduced fed-fasted effects
MX9700081A (en) Tacrine pharmaceutical compositions.
IL139681A0 (en) Pharmaceutical compositions containing vitamin b6
TR200002207T1 (en) Slekoksib compounds.
WO2007021805A3 (en) Estrogen compositions and therapeutic methods of use thereof
PT946151E (en) DOSAGE FORM OF GROWING DOSE
BR9916860A (en) Method of reducing blood cholesterol and / or other blood glycerides in a mammal individual, preparation in the form of a dosage unit, and, set to orally administer the same
EP2340839B1 (en) A composition of extracts from plants and the use thereof in prophylaxis or treatment of metabolism disorder of blood lipid
WO2017014502A1 (en) Pharmaceutical composition for preventing or treating il-6-mediated diseases comprising rosa rugosa flower extract as active ingredient
JP2002053485A (en) Pharmaceutical composition for allergic disease
CN106511161A (en) Traditional Chinese herbal medicine toothpaste with treatment effect on canker sore
CN101654393A (en) Compound as liver protective agent and compositions
MY117168A (en) Composition and method for treating nonalcoholic steatohepatitis
EP1173476A4 (en) Soybean protein nutraceuticals
CA2242589A1 (en) Composition containing diosgenin
NO974486L (en) Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation
CN101342223B (en) Jade butterfly beauty treatment speckle removing plaster and preparation method thereof
TW200517119A (en) Method of treatment using interferon-tau
US5108748A (en) Method of treatment during withdrawal from alcohol dependency
RU2097053C1 (en) Medicinal species for elimination of alcoholic addiction
Zakaria et al. Clinical efficacy of nicotine replacement therapy in the treatment of minor recurrent aphthous stomatitis
KR20030022500A (en) Composition of healthfood for skin-whitening